X
19
Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is ACETAMINOPHEN, with a corresponding application number 204052 and regulatory information .
proudly manufactured in the
approval since 2016-03-22
Sandoz B2B's ACETAMINOPHEN SOLUTION;INTRAVENOUS, medication with 1GM/100ML (10MG/ML) of ACETAMINOPHEN.